https://www.selleckchem.com/pr....oducts/cobimetinib-g
Transcatheter aortic valve implant has become a widely accepted treatment for inoperable patients with aortic stenosis and patients at high surgical risk. Its indications have recently been expanded to include patients at intermediate and low surgical risk. Our aim was to evaluate the efficiency of SAPIEN 3 vs conservative medical treatment (CMT) or surgical aortic valve replacement (SAVR) in symptomatic inoperable patients at high or intermediate risk. We conducted a cost-effectiveness analysis of SAPIEN 3 vs SAVR/C
Like
Comment
Share
